GlassScriptPhysician profile
Emily Ycasas
NPI 1033841861
$7,309.40
in general payments reported to CMS, 2019-2025
33 companies · $1,393 in 2025
The $1,393 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $821 · 2023: $1,844 · 2024: $3,253 · 2025: $1,393.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,477 · Travel and Lodging: $917 · Grant: $95.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,476.96 |
| Travel and Lodging | $916.87 |
| Grant | $95.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,848.77 | 2023-2025 | Watchman Flx, Watchman Access System, Farapulse |
| Abbott Laboratories | $907.99 | 2023-2025 | Aveir, Mitraclip, Ensite |
| Novo Nordisk INC | $440.46 | 2022-2025 | Ozempic, Rybelsus |
| Heartflow, INC. | $439.15 | 2024-2025 | |
| Edwards Lifesciences Corporation | $367.56 | 2022-2023 | Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $306.78 | 2022-2024 | Xarelto |
| Abiomed | $293.45 | 2024-2025 | Impella |
| Impulse Dynamics (USA) INC. | $251.27 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $247.63 | 2022-2024 | Lifevest |
| Abbvie INC. | $240.24 | 2023-2024 | |
| Amgen INC. | $207.07 | 2023-2025 | Krystexxa, Repatha |
| Actelion Pharmaceuticals US, INC. | $172.49 | 2022-2023 | Opsumit, Uptravi |
| Novartis Pharmaceuticals Corporation | $160.95 | 2022-2025 | |
| Shockwave Medical, INC | $157.57 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Merck Sharp & Dohme LLC | $129.38 | 2022-2025 | Verquvo, Winrevair |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $124.99 | 2024 | Cologuard Collection Kit |
| Daiichi Sankyo INC. | $123.67 | 2023 | Injectafer |
| Teva Pharmaceuticals USA, INC. | $122.37 | 2024 | Austedo Xr |
| Amarin Pharma, INC. | $111.44 | 2024 | |
| Phathom Pharmaceuticals, INC. | $110.57 | 2025 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $90.58 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $87.14 | 2023-2024 | Wainua, Farxiga |
| Alnylam Pharmaceuticals INC. | $64.13 | 2023-2024 | Amvuttra |
| Cvrx, INC. | $58.62 | 2023-2024 | Barostim Neo System |
| E.R. Squibb & Sons, L.L.C. | $40.49 | 2024-2025 | Eliquis, Camzyos |
| Kiniksa Pharmaceuticals, LTD. | $39.77 | 2022-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.51 | 2022-2024 | Jardiance |
| Kestra Medical Technology Services, INC. | $27.39 | 2022 | |
| Chiesi USA, INC. | $26.26 | 2025 | Juxtapid |
| Baxter Healthcare | $24.21 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kiniksa Pharmaceuticals International, Plc | $24.07 | 2024 | Arcalyst |
| Glaxosmithkline, LLC. | $15.76 | 2025 | Shingrix |
| Altathera Pharmaceuticals LLC | $12.67 | 2025 | Sotalol Hydrochloride |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Ycasas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.